Company Filing History:
Years Active: 2017
Title: Youngmin Lee: Innovator in Immune System Modulation
Introduction
Youngmin Lee is a prominent inventor based in Busan, South Korea. He has made significant contributions to the field of immunology, particularly in the modulation of the immune system. His innovative work has the potential to impact the treatment of diabetic patients.
Latest Patents
Youngmin Lee holds a patent for the "Use of proinsulin for immune system modulation." This patent describes a composition aimed at promoting immune activity, which includes proteins such as dimeric proinsulin and C-peptide partially deleted mutants. The invention also outlines a composition for immunosuppression that utilizes the C-peptide site of proinsulin. This research highlights the application of these components as immune enhancers for diabetic patients. He has 1 patent to his name.
Career Highlights
Youngmin Lee is affiliated with Konkuk University Industrial Cooperation Corporation, where he continues to advance his research and innovations. His work is characterized by a commitment to improving health outcomes through scientific discovery.
Collaborations
He collaborates with notable colleagues, including Soohyun Kim and Si-Young Lee, who contribute to his research endeavors.
Conclusion
Youngmin Lee's innovative work in immune system modulation showcases his dedication to advancing medical science. His contributions have the potential to significantly benefit diabetic patients and enhance immune responses.